Control of heme and cytochrome P-450 metabolism by inorganic metals, organometals and synthetic metalloporphyrins. by Kappas, A & Drummond, G S
Environmental Health Perspectives
Vol. 57, pp. 301-306, 1984
Control of Heme and Cytochrome P-450
Metabolism by Inorganic Metals, Organo-
metals and Synthetic Metalloporphyrins
by Attallah Kappas* and George S. Drummond*
The heme-cytochrome P-450 complexes represent sensitive metabolic systems for examining the
biological impact ofmetals on important cellular functions. Many metals, both in the inorganic form and
bound toorganic moieties, potently induce heme oxygenase, the rate limiting enzyme ofheme degradation.
The resulting increase in the rate of heme breakdown is reflected in a marked depression of cellular
cytochrome P-450 content and impairment of the oxidative metabolism of natural and foreign chemicals
dependent on this hemeprotein. Organometal complexes do not mimic in all their aspects the actions ofthe
inorganic elements which they contain. For example, organotins, in contrast to inorganic tin, produce a
prolonged induction response of heme oxygenase in the liver but not in the kidney. Co-protoporphyrin is a
much more potent inducer of heme oxygenase in liver than is inorganic cobalt; and Sn-protoporphyrin
inhibits heme oxygenase activity nearly completely, whereas inorganic tin is a powerful inducer of the
renal enzyme. Contrasting effects on heme metabolism exist as well within the metalloporphyrin species as
demonstrated by the effects in vivo of Co-protoporphyrin and Sn-protoporphyrin on heme oxygenase
activity; the former induces the enzyme whereas the latter potently inhibits it. In vitro, however, both
compounds competitively inhibit heme oxidation activity. These differences, among others which
characterize metal actions in vivo and in vitro attest to the importance of pharmacokinetic, adaptive and
other host factors in defining the responses ofthe heme-cytochrome P-450 systems to the impact ofmetals
in the whole animal.
Introduction
Environmental chemicals can produce detrimental
effects on cellular processes by perturbing the physio-
logic control mechanisms for important metabolic
systems. The heme-cytochrome P-450 complexes, which
play a central role in the oxidative metabolism or
detoxification of many foreign chemicals (1), are repre-
sentative ofsuch systems. The effects ofmany environ-
mental chemicals on specific aspects of heme metabo-
lism are moreover readily definable; for example, both
&-aminolevulinate (ALA) synthaseand heme oxygenase,
the rate-limiting enzymes of heme synthesis (2) and
degradation (3,4), respectively, are highly inducible
enzymes, and the resultant alterations in their activi-
ties produced by many chemicals can elicit marked
changes in cellular functions dependent on heme.
Metals, both inorganic (5) as well as complexed to
organic moieties (6), represent a major category of
environmental chemicals which can produce major per-
turbations of heme and cytochrome P-450 metabolism.
Some examples of these metal actions are summarized
in this report.
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Methods
Male (175-225 g) and 15-day synchronized pregnant
rats were purchased from Taconic Farms (Germantown,
NY) and Holtzman (Madison, WI), respectively. The
animals were maintained on standard rat chow and
drinking water ad libitum and were housed in the
Rockefeller University Laboratory Animal Research
Facility. Metalloporphyrins were purchased from Por-
phyrin Products (Logan, UT); diethyltin dichloride and
tricyclohexyltin were generous gifts ofthe M&T Chemi-
cal Company (Rahway, NJ). All other chemicals were of
the highest grade obtainable from either Fisher or
Sigma. Animals were treated as indicated in the figures
and table; microsomes were prepared and assays per-
formed as previously described (7,8).
Results
Effects of Inorganic Metals
on Heme Metabolism
Cobalt and other trace elements, as well as certain
heavy metals, are potent inducers ofheme oxygenase in
liver (5,9). The administration of cobalt to an animalKAPPAS AND DRUMMOND
produces a rapid rise in heme oxygenase activity which
reaches a maximum at 16 hr (Fig. 1) before gradually
declining to initial levels by 72 hr (5). This action
appears to reflect metal induction of de novo synthesis
of heme oxygenase (10). Concurrent perturbations of
ALA-synthase activity and a substantial depression of
cytochrome P-450 content also occur (Fig. 1). The
perturbations in ALA-synthase are characterized by an
early depression of enzyme activity followed by a
"rebound" phenomenon (10). The decline in cytochrome
P-450 content is accompanied by parallel decreases in
chemical biotransformations mediated by this heme-
protein. In addition to cobalt, inorganic elements such
as nickel, platinum, cadmium, tin and chromium, among
others, induce these marked but short-term alterations
in heme metabolism (5). The heme oxygenase inducing
action of metals has been studied extensively in liver
but also extends to other tissues (Fig. 2). Administra-
tion of inorganic tin results in an especially marked
increase of heme oxygenase in kidney (Fig. 2).
The heme oxygenase inducing action of some inor-
ganicmetals canbeblocked byotherinorganic elements.
For example, manganese when administered simulta-
neously with tin prevents the increase in heme oxygen-
ase induced bythe latter metal (Fig. 2); zinc also has the
same blocking effect (11). Manganese and zinc admini-
stration also prevents the decline in cytochrome P-450
content and the changes in ALA-synthase activity
associated with tin administration. The blocking effect
of these metals on heme oxygenase induction is lost
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when they are administered 10 min or more after the
inducer element (Fig. 2) indicating that the enzyme
synthetic process triggered by tin, and other metals, is
initiated rapidly after these inducers are administered.
Effects of Organometals
on Heme Metabolism
Organometals are compounds in which a central
metal atom is directly bound to a carbon atom of an
organic moiety; such complexes may have potent and
prolonged effects on heme metabolism in the liver and
other organs. For example, organometals containing
tin, such as tricyclohexyltin and diethyltin dichloride
(6), produce substantial increases in hepatic heme
oxygenase activity in contrast to inorganic tin which
does not under the same experimental conditions,
produce a significant increase in the activity of this
enzyme in liver (Thble 1). The effect of a single dose of
tricyclohexyltin on hepatic heme oxygenase is shown in
Figure 3. Heme oxygenase activity was significantly
increased, reaching a maximum 48 hr after organometal
administration; associated with the increase in enzyme
activity was a concurrent decrease in cytochrome P-450
content and characteristic perturbations in ALA-
synthase activity. These alterations inheme metabolism
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FIGURE 1. Effect of a single dose of cobalt chloride (250 ,umole/kg
body weight) on heme metabolism in liver. The metal was
administered subcutaneously in the nuchal region of adult male
rats. Each point represents the average of three animals killed at
the times indicated. (A) Cytochrome P-450 (nmole/mg); (0) ALA-
synthase (nmole ALA/mg/hr); (e) heme oxygenase (nmole bili-
rubin/mg per hr) x 10-1.
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FIGURE 2. Effect of the simultaneous administration of stannous
chloride (250 ,umole/kg body weight) and manganese chloride (250
,mole/kg body weight) on heme oxygenase activity in kidney.
Metals were administered at separate sites in the nuchal region of
adult male rats. Each point represents the average of three
animals killed at the times indicated. Inset: manganese chloride
was administered at the designated times, which ranged from 60
min before (-) to 60 min after (+) stannous chloride, which was
administered at zero time.
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extend for one week ormore after administration ofthis
organometal, in marked contrast to inorganic metals
which produce perturbations in heme metabolism which
are generally completed by 72 hr (5). In addition, while
inorganic tin is a potent inducer of heme oxygenase in
kidney (Fig. 2) but not in liver (Table 1), the reverse is
true for tricyclohexyltin (Table 1), indicating that
organification can change the tissue site of action of a
metal.
Effects of Synthetic Metalloporphyrins
on Heme Metabolism
A third group of metals which can perturb cellular
regulatory mechanisms for heme and cytochrome
P-450 metabolism are synthetic metalloporphyrins; i.e.,
metals, other than iron, which are complexed with the
protoporphyrin IX moiety. The duration and intensity
ofthe inducing effect on liverheme oxygenase produced
by a single dose (125 ,umole/kg body weight) of cobalt
protoporphyrin (Co-protoporphyrin) are shown in Fig-
ure 4. The enzyme inducing effect is striking in terms of
the marked elevation of heme oxygenase produced and
the prolonged period oftime -at least 21 days -during
which the enzyme activity remains elevated above
Table 1. Effects oftin and organotins on heme oxygenase activity
and cytochrome P-450 content in liver.a
Heme
oxygenase, nmole Cytochrome
Dose, bilirubin/mg P-450,
Treatment mg/kg body wt per hr nmole/mg
Saline 2.50 ± 0.14 0.74 ± 0.03
Inorganic tin 30 3.16 ± 0.19 0.69 ± 0.06
Diethyltin
dichloride 15 7.51 ± 0.31< 0.47 ± 0.01*
Tricyclohexyltin 15 4.75 ± 0.09* 0.49 ± 0.01
aAnimals were killed 16 hr after metal administration. Compounds
were administered subcutaneously in the nuchal region.
*p < 0.05 when compared to control (saline).
A Cytochrome P-450 (nmol/mg)
o ALA-synthose (nmol/mg per h)
* Heme oxygenase (nmol bilirubin/mg
per h) x 10-1
0 24 48 72 96 120 144 168 192 216
Time (h)
FIGURE 3. Effect of a single dose of tricyclohexyltin (40 ,umole/kg
bw) on heme metabolism in liver. Tricyclohexyltin was dissolved in
95% EtOH and administered subcutaneously in the nuchal region
of adult male rats. Each point represents the average of three
animals killed at the times indicated.
normal levels. A concomitant pronounced and sustained
depression ofcytochrome P-450isalsoproducedfollowing
administration of a single dose of Co-protoporphyrin;
the effect shown in Figure 4 lasted for at least 3 weeks.
The activities of cytochrome P-450 dependent enzymes
paralleled the depression of cellular cytochrome P-450
content. In addition, the activity ofALA-synthase was
markedly diminished throughout this time period. One
metabolic consequence of Co-protoporphyrin admini-
stration in the rat is arapid and profound suppression of
peripheral endocrine secretions (data not shown).
Polyacrylamide gel electrophoresis ofmicrosomal pro-
teins from Co-protoporphyrin treated animals revealed
a rapid loss ofmajor bands in the region ofMr 50,000 to
55,000 compared with microsomes isolated from control
animals (Fig. 5). The loss of these bands in the region
associated with various cytochrome P-450 species paral-
lels the loss in cytochrome P-450 content. The relation of
enhanced heme oxygenase activity and profoundly
diminished levels ofcytochrome P-450, to other expres-
sions of cellular toxicity is not clear. Thus one metal
inducer ofheme oxygenase, indium, has been shown to
produce significant morphological damage in liver (12);
while Co-protoporphyrin, which produces more pro-
nounced and sustained changes in heme oxygenase and
cytochrome P-450, elicits no structural alterations in
this organ (13).
The ability ofanother metalloporphyrin tin protopor-
phyrin (Sn-protoporphyrin) to alter heme metabolic
processes stands in marked contrast to the effects of
Co-protoporphyrin. Sn-protoporphyrin has the prop-
erty in vivo of potently inhibiting heme oxygenase
activity in liver, kidney and spleen (Fig. 6) by acting as a
competitive (nonmetabolized) substrate for the enzyme
(14,15). This effect is long-lasting in all tissues studied
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FIGURE 4. EffectofasingledoseofCo-protoporphyrin(125 ,umole/kg
body weight) on heme metabolism in liver. Co-protoporphyrin
was dissolved in 0.5N NaOH (0.2 mL/mL final volume), the pH
adjusted with 1N HCl to pH 7.4 and made up to final volume with
saline. The solution was then injected subcutaneously in the
nuchal region within 10 min ofpreparation. Each point represents
the average of three animals killed at the times indicated.
1.0
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(Fig. 6). The ability of Sn-protoporphyrin to inhibit
heme oxygenase in vivo forconsiderable periods oftime
has been explored in the neonate to determine whether
this metalloporphyrin could prevent the developmental
changes in heme degradation which characterize the
postnatal period (16) and whether the metalloporphyrin
could concomitantly suppress the hyperbilirubinemia
which occurs at this time. As shown in Figure 7,
Sn-protoporphyrin administration in a single dose at
birth produced a prompt decrease in hepatic heme
oxygenase activity; low levels of enzyme activity were
maintained throughout the 14-day study period; similar
results were noted in kidney. Sn-protoporphyrin also
prevented the normal postnatal increase ofsplenic heme
oxygenase (Fig. 7) and produced a prompt (within 24
hr) decline in serum bilirubin to levels comparable to
those in normal adult animals. Thus Sn-protoporphyrin
proved to be highly effective in suppressing the
hyperbilirubinemia that occurs in the immediate post-
natal period in this species. Chromium protoporphyrin
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FIGURE 6. Inhibitioninvivoofhemeoxygenasein(*)liver,(A)kidney
and (m) spleen in adult rats after a single administration of
Sn-protoporphyrin (5 ,umole/kg body weight). Sn-protoporphyrin
was prepared in an identical manner to Co-protoporphyrin (Fig. 4)
and administered by subcutaneous injection in the nuchal region.
Each time point represents the average of at least three animals
killed at the times indicated.
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FIGURE 5. NaDodSO4/polyacrylamide gel electrophoresis ofhepatic
microsomal proteins isolated from control and Co-protoporphyrin
(cobalt PP, 125 ,umole/kg body weight)-treated rats at the times
indicated. The gels were run on the basis of equal amounts of
microsomal protein and were stained with Coomassie Blue. The
stacking and separating gels contained 5% and 7.5% acrylamide,
respectively.
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FIGURE 7. Inhibition in vivo of heme oxygenase in the liver and
spleen of rat neonates after a single administration of Sn-
protoporphyrin (10 ,umole/kg body weight) at birth: (e) liver heme
oxygenasecontrol; (o)treated;(A)spleenhemeoxygenasecontrol;
(A) treated. The compound was prepared in an identical mannerto
Co-protoporphyrin (Fig. 4). Each time point represents the
average of 12 (later points) to 30 (earlier points) neonates. The
total bilirubin levels (inset) were determined fluorometrically on
pooled serum samples of (e) control and (o) treated neonates as
described earlier (14).
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The heme-cytochrome P-
tive metabolic systems ft
metals on important cellulb
als (Figs. 1 and 2), organo
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degradation, heme oxygenm
rate of heme degradation.'
cellular cytochrome P-450
the oxidative metabolism of xenobiotics reflect this
increased heme breakdown. The net effect of these
Co-protoporphyrin changes is to diminish the capacity ofthe liver to carry
out cytochrome P-450-dependent inactivation of chemi-
cal substances forwhich oxidative metabolism results in
biological inactivation.
Inorganic elements such as cobalt or tin produce
short-term though pronounced alterations in heme
metabolism (Figs. 1 and 2). Organification ofthe metal
may lead to a marked prolongation of the induced
perturbations in heme metabolism (Figs. 3 and 4); these
toporphyrin /Snprotoporphyrin effects occur with considerably lower doses of the
organometals compared with those of the inorganic
elements which they contain. In addition, studies with
I I I I I mmmmmmmmmmmm0www7ooagorganotins reveal that organification of a metal can also '40 50 60 70 80 90 lead to a shift in the organ site of its action. rime (h) Complexed metals may not mimic in all respects the
phyrin administration on Co-proto- effects oftheirinorganic elements on heme metabolism.
xygenase in the liver ofadult male The striking difference in potency of heme oxygenase
were administered in a dose of 50 induction by inorganic cobalt (Fig. 1) and Co- otoporphyrin was administered 30 protoporphyrin (Fig. 4) attests to this fact; as does the
rhe route of administration was by . . .
ate sitesinthe nuchalregion. Each inablity of Sn-protoporphyrin to induce heme oxygen-
fat least three animals killed at the ase activity in kidney (Fig. 6) whereas inorganic tin is a
powerful inducer of the enzyme in this organ (5,11).
Whether the potent inhibitory effect of Sn-proto-
a similar suppressive effect porphyrin on heme oxygenase activity obscures an
)ut other metalloporphyrins underlying ability of the metalloporphyrin to also in-
porphyrin and Zn-protopor- duce de novo synthesis ofthe enzyme protein remains to
ly large amounts, show this be determined by appropriate immunological means. In
even though they can inhibit the case of Co-protoporphyrin, both actions can be
a vitro (14,15,18). Co-proto- manifest-an inhibitory effect ofthe compound in vitro
eme oxygenase activity in (15) and an enzyme inducing effect in vivo (7). In
this metalloporphyrin has addition, markedly contrasting effects on heme metabo-
eptionally potent inducer of lismexistwithin themetalloporphyrin species asdemon-
the ability of a synthetic strated by the in vitro and in vivo studies with
titively inhibit heme oxygen- Co-protoporphyrin and Sn-protoporphyrin (7,14).
that the compound can also Metals, in the inorganic form or as complexes, can
ia in the whole animal. also exert useful experimental, and possibly clinical,
inhibit heme oxygenase effects on heme metabolism. Simultaneous administra-
animals and in neonates, but tion of manganese or zinc with tin for example (Fig. 2)
enzyme has been previously prevents the occurrence of the characteristic, and
or by Co-protoporphyrin presumably deleterious perturbations of heme metabo-
a also suppresses the hyper- lism associated with the administration of tin alone.
ith severe genetic hemolytic Sn-protoporphyrin is a potent inhibitor in vivo of heme
that produced by bile duct oxygenase activity in normal animals and in animals in
:n of large amounts of heme which the enzyme has been previously induced by
.A in rats (20,21). another agent, e.g., Co-protoporphyrin (Fig. 8) or in
animals, i.e., neonates, in which the enzyme activity
has been induced by the heme of hemoglobin derived
from the postnatal lysis of fetal red cells. Sn-
450complexesprovidesensi- protoporphyrin when administered immediately after
cr studying the impact of birth has been successfully employed (14,17) in the
ar functions. Inorganic met- latter circumstance to suppress or prevent the
metals (Table 1 and Fig. 3) hyperbilirubinemia that occurs in the neonate (Fig. 7).
hyrins (Fig. 4) can all po- This action of Sn-protoporphyrin, which also extends to
limiting enzyme of heme Cr-protoporphyrin (8), affirms the suggestion made
ase, resulting in an enhanced from this laboratory in 1975 (16) that it may be possible
The associated depression of to approach, therapeutically, the problem of neonatal
content and impairment of jaundice by considering means for suppressing the
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enhanced rates oftissue heme oxidation activity which
characterize the newborn and which contribute to the
hyperbilirubinemia which occurs in the neonatal period.
Our initial clinical studies with Sn-protoporphyrin
confirm that the ability of this compound to suppress
excessive hyperbilirubinemia in animals also extends to
humans (20).
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